Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

<div>Changes in area stenosis from baseline to 1 year after treatment. (a) Changes in stenosis by patient; (b) mean changes in the stenosis.</div>

Journal of Interventional Cardiology

fig1

Figure 1

Figure 1: Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients 

Figure 1 | Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients 